Chemours/$CC
1D1W1MYTD1Y5YMAX
Capital at risk
About Chemours
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
- Ticker
- $CC
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 5,700
- Headquarters
- Wilmington, United States
- Website
- www.chemours.com
Chemours Metrics
BasicAdvanced
$2.1B
-
-$2.03
1.42
$0.35
2.48%
Price and volume
Market cap
$2.1B
Beta
1.42
52-week high
$28.67
52-week low
$10.44
Average daily volume
1.7M
Dividend rate
$0.35
Financial strength
Current ratio
1.663
Quick ratio
0.848
Long term debt to equity
-83.938
Total debt to equity
-84.646
Interest coverage (TTM)
0.61%
Profitability
EBITDA (TTM)
533
Gross margin (TTM)
15.40%
Net profit margin (TTM)
-5.24%
Operating margin (TTM)
2.86%
Effective tax rate (TTM)
-510.00%
Revenue per employee (TTM)
$1,020,000
Management effectiveness
Return on assets (TTM)
1.42%
Return on equity (TTM)
-319.37%
Valuation
Price to revenue (TTM)
0.367
Price to book
-43.39
Price to tangible book (TTM)
-21.92
Price to free cash flow (TTM)
9.768
Free cash flow yield (TTM)
10.24%
Free cash flow per share (TTM)
1.447
Dividend yield (TTM)
2.48%
Forward dividend yield
2.48%
Growth
Revenue change (TTM)
-0.91%
Earnings per share change (TTM)
-29.17%
3-year revenue growth (CAGR)
-2.70%
10-year revenue growth (CAGR)
0.48%
3-year earnings per share growth (CAGR)
51.48%
10-year earnings per share growth (CAGR)
16.03%
3-year dividend per share growth (CAGR)
-29.53%
10-year dividend per share growth (CAGR)
14.55%
What the Analysts think about Chemours
Analyst ratings (Buy, Hold, Sell) for Chemours stock.
Analyst projections of the future price of Chemours stock.
Bulls say / Bears say
Chemours generated $114 million of free cash flow in the second quarter, up 128% year on year, and repaid €230 million of term debt. Management still targets 2026 adjusted EBITDA of $775–825 million and year-end net leverage of about 3.8 times. (PR Newswire)
Titanium Technologies is beginning to show pricing power: three increases have lifted TiO2 pricing by about 5% year to date. The segment’s sales rose 18% sequentially in the second quarter, and further price and cost improvements are expected to support the recovery. (PR Newswire)
Chemours is gaining exposure to higher-growth specialty markets. APM Performance Solutions sales grew 8% year on year, while new low-GWP Opteon refrigerants target expanding data-centre and other high-load chiller applications. (PR Newswire, PR Newswire)
The main near-term earnings drag is excess inventory in the North American aftermarket for Opteon blends. Chemours expects third-quarter TSS sales to fall by roughly the mid-teens to 20% sequentially as destocking and weaker seasonal demand continue. (PR Newswire)
TiO2 pricing is masking weak underlying demand rather than reflecting a broad volume recovery. Titanium Technologies volumes fell 2% year on year in the second quarter, while overall company volumes fell 4%, leaving revenue roughly flat despite higher prices. (PR Newswire)
Chemours remains financially exposed to its legacy environmental liabilities while carrying substantial debt. Second-quarter gross debt was $3.9 billion and net leverage was 4.4 times, while the company also agreed to a $455 million North Carolina PFAS settlement and warned that adverse legal outcomes could hurt liquidity. (PR Newswire, PR Newswire)
Data summarised monthly by Lightyear AI. Last updated on 28 Sept 2026.
Chemours Financial Performance
Revenues and expenses
Chemours Earnings Performance
Company profitability
Upcoming events
No upcoming events
Chemours News
AllArticlesVideos
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination
Business Wire3 weeks ago
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
Reuters3 weeks ago
Chemours Q2 Earnings Call Highlights
MarketBeat2 months ago
Funds containing Chemours
AllUSDGBPEUR
Fund name | Fund size | $CC weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.13% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.13% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.07% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.07% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.